Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 32094.79 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Scrap and Sale of services for the year ending 31-Mar-2021.
Financials
For the quarter ended 31-03-2022, the company has reported a Consolidated Total Income of Rs 5858.25 Crore, down -3.44 % from last quarter Total Income of Rs 6067.21 Crore and down -3.64 % from last year same quarter Total Income of Rs 6079.60 Crore. Company has reported net profit after tax of Rs 580.25 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 51.83 per cent stake in the company as of 31-Mar-2022, while FIIs owned 22.48 per cent, DIIs 15.82 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.